So we continue to be at an impasse. Persons will keep on to just take medicines—blindly, In most cases—and a lot of will subsequently run the potential risk of overdose and Loss of life. But When the authorities received’t offer information and applications for damage minimisation, We're going to.MAPS just isn't supporting off-label use for M